Article info

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

Authors

  • Rebecca H Haberman Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USANYU Langone Psoriatic Arthritis Center, New York University School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Ramin Herati Divison of Infectious Disease and Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY, USANew York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • David Simon Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, GermanyDeutsches Zentrum fuer Immuntherapie (DZI), Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Marie Samanovic Divison of Infectious Disease and Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY, USANew York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Rebecca B Blank Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USANew York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Michael Tuen Divison of Infectious Disease and Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY, USANew York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Sergei B Koralov Department of Pathology, New York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Raja Atreya Deutsches Zentrum fuer Immuntherapie (DZI), Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, GermanyDepartment of Internal Medicine 1, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Koray Tascilar Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, GermanyDeutsches Zentrum fuer Immuntherapie (DZI), Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Joseph R Allen Divison of Infectious Disease and Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY, USA PubMed articlesGoogle scholar articles
  • Rochelle Castillo Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USANYU Langone Psoriatic Arthritis Center, New York University School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Amber R Cornelius Divison of Infectious Disease and Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY, USA PubMed articlesGoogle scholar articles
  • Paula Rackoff Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Gary Solomon Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Samrachana Adhikari Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA PubMed articlesGoogle scholar articles
  • Natalie Azar Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Pamela Rosenthal Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Peter Izmirly Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Jonathan Samuels Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USADepartment of Medicine, NYU Langone Orthopedic Hospital, New York, New York, USA PubMed articlesGoogle scholar articles
  • Brian Golden Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Soumya M Reddy Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USANYU Langone Psoriatic Arthritis Center, New York University School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Markus F Neurath Deutsches Zentrum fuer Immuntherapie (DZI), Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Steven B Abramson New York University Grossman School of Medicine, New York, New York, USARheumatology Research, NYU-NYU Langone Orthopedic Hospital, New York, New York, USA PubMed articlesGoogle scholar articles
  • Georg Schett Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, GermanyDeutsches Zentrum fuer Immuntherapie (DZI), Friedrich-Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Mark J Mulligan Divison of Infectious Disease and Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University School of Medicine, New York, NY, USANew York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Jose U Scher Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USANYU Langone Psoriatic Arthritis Center, New York University School of Medicine, New York, New York, USANew York University Grossman School of Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jose U Scher, New York University School of Medicine, New York, NY 10003, USA; jose.scher{at}nyulangone.org
View Full Text

Citation

Haberman RH, Herati R, Simon D, et al
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

Publication history

  • Received April 20, 2021
  • Accepted May 10, 2021
  • First published May 25, 2021.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.